Akso Health (AHG) Current Deferred Revenue (2018 - 2025)

Akso Health has reported Current Deferred Revenue for 6 years, with the latest figure at $8.0 million in Q3 2025.

• For the quarter ending Q3 2025, Current Deferred Revenue rose 131.68% year-over-year to $8.0 million; the trailing twelve-month figure through Sep 2025 stood at $8.0 million (up 131.68% YoY), and the FY2025 full-year result was $10.2 million, up 2361.82% from the prior year.
• Current Deferred Revenue for Q3 2025 stood at $8.0 million, down from $10.2 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $10.2 million in Q1 2025, with the low at $194376.0 in Q1 2023.
• Historically, Current Deferred Revenue has averaged $3.8 million across 3 years, with a median of $1.9 million in 2023.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue surged 113.51% — and 2025, when it jumped 2361.82%.
• Akso Health's Current Deferred Revenue stood at $415020.0 in 2023, then surged by 730.86% to $3.4 million in 2024, then soared by 131.68% to $8.0 million in 2025.
• The last three Current Deferred Revenue figures came in at $8.0 million (Q3 2025), $10.2 million (Q1 2025), and $3.4 million (Q3 2024), per Business Quant data.